These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27658259)

  • 1. Correction: Microneutralization Assay Titres Correlate with Protection against Seasonal Influenza H1N1 and H3N2 in Children.
    Verschoor CP; Singh P; Russell ML; Bowdish DM; Brewer A; Cyr L; Ward BJ; Loeb M
    PLoS One; 2016; 11(9):e0163830. PubMed ID: 27658259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1.
    Zhang R; Rong X; Pan W; Peng T
    Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
    Allen JD; Ray S; Ross TM
    PLoS One; 2018; 13(12):e0210043. PubMed ID: 30589902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of single-tube multiplex real-time PCR for simultaneous detection of novel influenza A H1N1 and human seasonal influenza A H1N1 and H3N2 virus].
    Qin M; Wang DY; Huang F; Nie K; Qu M; Wang M; Han F; Zhao X; Cheng YH; Shu YL; Ma XJ
    Bing Du Xue Bao; 2010 Mar; 26(2):97-102. PubMed ID: 20480637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections.
    Belongia EA; Irving SA; Waring SC; Coleman LA; Meece JK; Vandermause M; Lindstrom S; Kempf D; Shay DK
    JAMA; 2010 Sep; 304(10):1091-8. PubMed ID: 20823435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pandemic A/H1N1/2009 influenza on children and their families: comparison with seasonal A/H1N1 and A/H3N2 influenza viruses.
    Esposito S; Molteni CG; Daleno C; Tagliabue C; Picciolli I; Scala A; Pelucchi C; Fossali E; Principi N
    J Infect; 2011 Oct; 63(4):300-7. PubMed ID: 21839113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological report of pandemic and seasonal human influenza virus infection in dogs in southern China.
    Yin X; Zhao FR; Zhou DH; Wei P; Chang HY
    Arch Virol; 2014 Nov; 159(11):2877-82. PubMed ID: 24965232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprotective antibodies to 2011 variant influenza A(H3N2v) and seasonal influenza A(H3N2) among three age groups of US Department of Defense service members.
    Radin JM; Hawksworth AW; Ortiguerra RG; Brice GT
    PLoS One; 2015; 10(3):e0121037. PubMed ID: 25816244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
    Fullen DJ; Noulin N; Catchpole A; Fathi H; Murray EJ; Mann A; Eze K; Balaratnam G; Borley DW; Gilbert A; Lambkin-Williams R
    PLoS One; 2016; 11(6):e0157211. PubMed ID: 27280602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
    Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
    Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Discrimination of influenza infection (A/2009 H1N1) from prior exposure by antibody protein microarray analysis.
    The
    PLoS One; 2015; 10(2):e0118047. PubMed ID: 25658917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune protective effectiveness of seasonal influenza spilt vaccine against homologous and heterogonous subtypes of influenza virus in mice].
    Huang BY; Wang XP; Wang WL; Hu W; Gao Q; Tan WJ; Ruan L
    Bing Du Xue Bao; 2011 May; 27(3):265-73. PubMed ID: 21774253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy.
    Ottóffy G; Horváth P; Muth L; Sólyom A; Garami M; Kovács G; Nyári T; Molnár D; Pauler G; Jankovics I
    Pediatr Blood Cancer; 2014 Jun; 61(6):1013-6. PubMed ID: 24395342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies.
    Roos A; Roozendaal R; Theeuwsen J; Riahi S; Vaneman J; Tolboom J; Dekking L; Koudstaal W; Goudsmit J; Radošević K
    Vaccine; 2015 Mar; 33(14):1739-47. PubMed ID: 25659276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children.
    Black S; Nicolay U; Vesikari T; Knuf M; Del Giudice G; Della Cioppa G; Tsai T; Clemens R; Rappuoli R
    Pediatr Infect Dis J; 2011 Dec; 30(12):1081-5. PubMed ID: 21983214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need for quadrivalent vaccine against seasonal influenza.
    Belshe RB
    Vaccine; 2010 Sep; 28 Suppl 4():D45-53. PubMed ID: 20713260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody persistence and serological protection among seasonal 2007 influenza A(H1N1) infected subjects: Results from the FLUREC cohort study.
    Delabre RM; Salez N; Lemaitre M; Leruez-Ville M; de Lamballerie X; Carrat F
    Vaccine; 2015 Dec; 33(49):7015-21. PubMed ID: 26387434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.